How long should Ensidipine be used for?
The duration of use of enasidenib should be determined based on the patient's specific condition and the guidance of the physician.
The recommended starting dose of ensidipine is100 mg taken orally once daily with or without food until disease progression or unacceptable toxicity. For patients without disease progression or unacceptable toxicity, the minimum duration of treatment is 6 months to allow assessment of clinical response.
The duration of ensidipine use depends primarily on the patient's disease progression. If the patient's condition is controlled while on ensidipine and there are no signs of disease progression, treatment with ensidipine can be continued. Conversely, if the condition progresses, treatment may need to be adjusted.
Patient tolerance is also an important factor affecting the duration of ensidipine use. Some patients may not be able to tolerate the side effects of ensidipine, such as nausea, vomiting, diarrhea, increased bilirubin levels, etc., and may need to reduce the dose or discontinue use.
Doctors will guide the duration of use of ensidipine based on the patient's specific situation and efficacy evaluation. During the treatment process, doctors will regularly monitor the patient's leukemia indicators and physical condition and make adjustments as necessary.
Do not split or crush ensidipine tablets. Tablets should be swallowed whole without splitting or crushing. Ensidipine should be taken orally at the same time every day to maintain stable blood concentrations. While taking ensidipine, patients should undergo regular blood tests and other relevant examinations to evaluate the drug's efficacy and safety.
The duration of use of ensidipine should be determined based on the patient's specific condition and the guidance of the doctor. Generally, the minimum duration of treatment is 6 months to allow assessment of clinical response. However, the specific duration of use may vary depending on disease progression, patient tolerance and other factors. During the treatment process, patients should communicate closely with their doctors, monitor their physical condition regularly, and make adjustments as needed. At the same time, patients should also pay attention to the storage conditions and usage methods of the drugs to ensure the efficacy and safety of the drugs.
References:
https://www.medicalnewstoday.com/articles/drugs-epi-pen-expiration
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)